glp-1 trends Analogues Market Report, Growth and Forecast Recent Trends in GLP-1 Use
Description
Zero prep required
More than half of the adults in the study lost more than 10 percent of their body weight
Pricing is subject to change without notice
Saxenda, also a once daily injection, is approved for weight loss in children at least 12 years old and adults diagnosed with obesity
Supplementary Materials Data Availability Statement No data were analysed in the study
Nuffield Department of Population Health Renal Studies Group
